CAH Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Cardinal Health Inc (CAH) is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The company demonstrates strong financial growth, positive analyst sentiment, and strategic advantages in advanced therapies. While there are no immediate trading signals from Intellectia Proprietary Trading Signals, the stock's bullish technical indicators and favorable long-term outlook make it a solid investment choice.
The stock shows bullish moving averages (SMA_5 > SMA_20 > SMA_200), indicating an upward trend. The MACD is positive at 0.48, though contracting, and RSI is neutral at 48.612. The stock is trading close to a key support level (S1: 211.233), suggesting limited downside risk. Pivot level at 214.052 indicates potential for upward movement.
Strong Q2 financial performance with revenue up 18.75% YoY and EPS up 19.39% YoY.
Strategic advantage in advanced therapies and community healthcare partnerships.
Positive analyst sentiment with multiple price target increases, most recently to $240 by Evercore ISI.
Bullish technical indicators and favorable moving averages.
No immediate trading signals from Intellectia Proprietary Trading Signals.
Stock trend analysis indicates potential short-term downside (-1.46% in the next week, -3.87% in the next month).
In Q2 2026, Cardinal Health reported strong financial growth: Revenue increased by 18.75% YoY to $65.63 billion, Net Income rose 16.75% YoY to $467 million, EPS grew by 19.39% YoY to $1.97, and Gross Margin improved by 3.83% YoY to 3.52%.
Analysts are overwhelmingly positive on CAH, with multiple firms raising price targets after strong Q2 results. Recent price targets range from $233 to $260, with most analysts maintaining 'Outperform' or 'Overweight' ratings. The consensus reflects confidence in the company's business strength and growth potential.
